Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1255667-06-1

Post Buying Request

1255667-06-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1255667-06-1 Usage

General Description

1-Tert-butyl 3-methyl 5,5-difluoropiperidine-1,3-dicarboxylate is a chemical compound that belongs to the class of piperidine dicarboxylates. It is a colorless liquid with a molecular weight of 261.29 g/mol. This chemical is commonly used in pharmaceutical research and as a building block in the synthesis of various biologically active compounds. It is known for its potential use in the development of new drugs, particularly for its ability to target specific receptors and biological pathways. Additionally, it is often used as a reference standard in analytical chemistry for the determination of piperidine derivatives in various samples. Its unique molecular structure and properties make it a valuable tool in drug discovery and development processes.

Check Digit Verification of cas no

The CAS Registry Mumber 1255667-06-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,5,6,6 and 7 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1255667-06:
(9*1)+(8*2)+(7*5)+(6*5)+(5*6)+(4*6)+(3*7)+(2*0)+(1*6)=171
171 % 10 = 1
So 1255667-06-1 is a valid CAS Registry Number.

1255667-06-1Relevant articles and documents

QUINAZOLINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF

-

, (2022/01/12)

Provided herein are novel compounds, for example, compounds having a Formula (I), Formula (II), or Formula (III), or a pharmaceutically acceptable salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KRAS G12D in a cancer cell, and/or in treating various cancer such as pancreatic cancer, colorectal cancer, lung cancer or endometrial cancer.

INHIBITORS OF MYOCARDIN-RELATED TRANSCRIPTION FACTOR AND SERUM RESPONSE FACTOR (MRTF/SRF)-MEDIATED GENE TRANSCRIPTION AND METHODS FOR USE OF THE SAME

-

, (2016/06/01)

Disclosed herein are inhibitors of gene transcription mediated by myocardin-related transcription factor and serum response factor, or both myocardin-related transcription factor and serum response factor ("MRTF/SRF"), and methods for their use in treating or preventing cancer and fibrosis. In particular, disclosed herein are compounds of Formula (I) and Formula (II), and pharmaceutically acceptable salts thereof: wherein the substituents are as described.

SUBSTITUTED [1,2,4] TRIAZOLO [1,5-A] PYRIMIDIN-7-YL COMPOUNDS AS PDE2 INHIBITORS

-

, (2015/11/10)

The invention provides a chemical entity of Formula (I): wherein R1, R2, X, Y and Z have any of the values described herein, and compositions comprising such chemical entities; methods of making them; and their use in a wide range of

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1255667-06-1